Medicated Skin Care Products Industry Outlook 2025-2030: Increased OTC Product Demand, Innovations in Formulations, and the Expansion of Online Retail Presents Investment Opportunities
Medicated Skin Care Products Market
Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Medicated Skin Care Products - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Medicated Skin Care Products was valued at US$7.6 Billion in 2024 and is projected to reach US$9.2 Billion by 2030, growing at a CAGR of 3.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Medicated Skin Care Products market.
The growth in the medicated skin care products market is driven by several factors. Firstly, the increasing incidence of skin conditions, driven by factors such as pollution, lifestyle changes, and dietary habits, is propelling the demand for effective treatments. Secondly, advancements in dermatological research and pharmaceutical formulations are leading to the development of more targeted and efficient products. Thirdly, the growing consumer preference for self-medication and OTC treatments is increasing the accessibility and usage of medicated skin care products. Lastly, the expansion of online retail and direct-to-consumer channels is making it easier for consumers to access a wide range of specialized skin care solutions. These factors collectively contribute to the robust growth of the medicated skin care products market.
Key Insights:
Market Growth: Understand the significant growth trajectory of the Cleansers segment, which is expected to reach US$2.9 Billion by 2030 with a CAGR of a 2.9%. The Toners segment is also set to grow at 2.6% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, valued at $2.4 Billion in 2024, and China, forecasted to grow at an impressive 4.7% CAGR to reach $1.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
Detailed Market Analysis: Access a thorough analysis of the Global Medicated Skin Care Products Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Medicated Skin Care Products Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
How is the Global Medicated Skin Care Products Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?
Report Features:
Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of players such as Allergan Aesthetics, 3M Company, Bayer AG, Beiersdorf AG, AdvoCare International LP and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 251 companies featured in this Medicated Skin Care Products market report include:
Allergan Aesthetics
3M Company
Bayer AG
Beiersdorf AG
AdvoCare International L.P.
ALBION Co., Ltd.
4life Trademarks, L.L.C.
Absolutely Natural
Amarte USA LLC
Abbe Laboratories, Inc.
Bee-Alive, Inc.
Bausch Health Companies Inc.
Advanced Dermatology and Cosmetic Surgery
Beauty Solutions, Limited
Brevena
The report analyzes the Medicated Skin Care Products market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments: Type (Cleansers, Toners, Scrubs & Masks, Serums, Moisturizers); Distribution Channel (Offline, Online)
Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Key Attributes
Report Attribute
Details
No. of Pages
715
Forecast Period
2024-2030
Estimated Market Value (USD) in 2024
$7.6 Billion
Forecasted Market Value (USD) by 2030
$9.2 Billion
Compound Annual Growth Rate
3.1%
Regions Covered
Global
MARKET OVERVIEW
Tariff Impact on Global Supply Chain Patterns
Competition
Medicated Skin Care Products - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
Medicated Skin Care Products: An Introduction
Growing Prevalence of Skin Diseases and the Unmet Treatment Needs: A Fundamental Growth Driver
Major Skin Diseases Driving the Need for Medicated Skincare Products
Recent Market Activity
MARKET TRENDS & DRIVERS
Medicated Skin Care Domain to Have Real Moment with Innovation Focus
Select Recently Launched Innovative Skin Care Brands
Trending Ingredients for Skin Care Products
Medical Skin Care Products Rank Better than Regular OTC Products
Growing Demand for Products with Visible Results to Push Growth
Rising Incidence of Skin Issues among Children Fuels Demand for Medicated Skincare Products
Increasing Incidence of Skin Cancer Spurs Demand for Dermatological Products
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Multiple Skin Changes During Cancer Treatment Offers Opportunities
Incidence of Different Types of Skin Cancer
Growing Prevalence of Psoriasis Widens the Demand
Rising Incidence of Eczema to Underpin Volume Growth
Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth
Health & Wellness Boosts Demand for Dermocosmetics
Growth in the Global Cosmeceuticals Market Bodes Well for Market Growth
Global Cosmeceutical Market Size (in US$ Billion) for 2019, 2022 and 2025
Cosmeceuticals with Biologically Active Ingredients to Improve Skin Functioning Begin to Find Favor
Rise in Young Population and Skin Conditions Such as Acne Drive Demand for Medicated skin Care Products
Aging Population and their Vulnerability to Age-Related Skin Changes: A Strong Growth Driver
Major Anti-Aging Ingredients of Cosmeceuticals
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Research-Backed Ingredients Hold Preference
Growing Prominence of Personalized Skin Care Prescriptions Benefit Market Penetration
AI Skin Technology Opening New Opportunities for Ultra-Personalized Skincare Shopping
Medicated Skin Care Advancements DriveGrowth
Nano Gold Products Emerge for Combating Aging
Consumer Interest in Natural Ingredients Drive Demand for Natural and Organic Products
Demand for Natural Ingredients for Cosmetic Products Surges
Surging Popularity of Multi-Functional Products Promote Market Expansion
Women: The Dominant Consumer Cluster for Skin Care Products
Physiological Differences Entail Need for Male Specific Products
Gen Z Emerge as an Attractive Target
Focus Grows on Finding Alternatives to Hydroquinone for Pigment Control
Growing Prominence of Non-Invasive Skin Treatments Lends Traction to Market Demand
Growing Online Availability of Medical-Grade Products and Concerns
Increasing Environmental Pollution Drive Demand for Anti-Pollution Skin Care Products
For more information about this report visit https://www.researchandmarkets.com/r/tp65no
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Medicated Skin Care Products Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
7 minutes ago
- Bloomberg
Hedge Funds Rush Into Bullish Oil Bets as Trump Pressures Russia
Hedge funds boosted their bullish bets on crude oil at the fastest pace in over a month as US President Donald Trump's threat of additional levies on Russia drove fears about tighter supplies. Money managers increased their combined net-long position on West Texas Intermediate and Brent by 39,779 lots to 299,295, in the week ending July 29, according to data from ICE Futures Europe and the US Commodity Futures Trading Commission compiled by Bloomberg. That was the biggest increase since mid-June, when the conflict between Israel and Iran escalated.
Yahoo
9 minutes ago
- Yahoo
Norwegian Cruise Line shares surge after record second quarter revenue
-- Norwegian Cruise Line Holdings Ltd. reported record second-quarter revenue of $2.52 billion, up 6% YoY, though slightly below analyst expectations of $2.56 billion. The company posted adjusted earnings per share of $0.51, narrowly missing the consensus estimate of $0.52, but demonstrating strong consumer demand across its brands. Norwegian's shares surged 9.6% following the announcement as investors responded positively to the company's strong performance and reaffirmed full-year guidance. The cruise operator reported that bookings have rebounded across all three of its brands, with booking levels now exceeding historical patterns in recent months. The company delivered adjusted EBITDA of $694 million, exceeding its guidance of $670 million. Net yield increased approximately 2.7% on an as-reported basis and 3.1% in constant currency, outperforming guidance of approximately 2.5%. Gross margin per capacity day increased 11% compared to the same period in 2024. "We delivered another record quarter, demonstrating once again the strong customer demand environment, the power of our brands, our outstanding onboard product, and the dedication of our team," said Harry Sommer, president and CEO of Norwegian Cruise Line (NYSE:NCLH) Holdings. Norwegian maintained its full-year 2025 guidance, projecting adjusted EPS of $2.05, representing a 16% increase from 2024. The company expects full-year net yield to increase approximately 2.5% on a constant currency basis versus 2024. The cruise operator also announced expansion plans for its private island destination, Great Stirrup Cay in the Bahamas, including a nearly six-acre waterpark expected to open in summer 2026. Additionally, the company took delivery of Oceania Allura and confirmed orders for two additional next-generation ships. Related articles Norwegian Cruise Line shares surge after record second quarter revenue Apollo economist warns: AI bubble now bigger than 1990s tech mania If Powell goes, does Fed trust go with him? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
France's FDJ slides after gaming group calls current year one of "transition"
- Shares of La Francaise des Jeux slipped by more than 10% on Thursday after the French gaming company called its current fiscal year one of "transition" and analysts flagged "few catalysts" on the horizon. FDJ, whose offerings include scratch cards in France, posted first-half revenue of 1.87 billion euros, an uptick of 31% versus a year earlier but down 2% on a restated basis. Lottery revenues rose by 6% to 1.07 million euros, fueled in large part by FDJ's digital operations. However, point-of-sale sports betting sales dropped by 6% to 225 million euros, reflecting "unfavorable sports results" for the operator, FDJ said. Online betting and gaming was also a weak spot of FDJ's top-line result, slipping by 12% on a restated basis to 466 million euros, due in particular to a stronger comparison driven by last summer's Euro football tournament as well as recent tax and regulatory policies in the Netherlands and U.K. Excluding those two markets, revenue at the segment would be higher by 5%. Adjusted net income stood at 222 million euros, which FDJ said reflected the impact of financing related to its acquisition of Swedish peer Kindred and "the one-off tax contribution on the profits of large French companies." FDJ reiterated its 2025 targets for stable pro forma revenue and a recurring core income margin of over 24%. Related articles France's FDJ slides after gaming group calls current year one of "transition" Victoria's Secret Exposed: The Warning Sign Behind the Stock's 52% Collapse Surge of 50% since our AI selection, this chip giant still has great potential Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
